Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,109,645
+$3,441,574 QoQ
Shares Held
16,766
-7.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.83%
of 13F equity value
Holder Rank
#888
of 4,605 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALERUS FINANCIAL NA holds $65,318,341 across 13 Drug Manufacturers - General names. LLY ranks #1 (30.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
16,766 | $20,109,645 | |
| 2 | JNJ |
Johnson & Johnson
|
74,659 | $18,961,146 | |
| 3 | ABBV |
AbbVie Inc.
|
48,063 | $12,094,573 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,144 | $8,242,504 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
42,984 | $2,476,738 | |
| 6 | PFE |
Pfizer Inc
|
87,204 | $2,099,872 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,022 | $1,139,839 | |
| 8 | AZN |
Astrazeneca PLC
|
586 | $111,117 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,109,645 | 16,766 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,668,071 | 18,122 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $21,175,496 | 19,704 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $15,295,861 | 20,047 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $14,991,141 | 19,231 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $15,977,228 | 19,345 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $14,976,800 | 19,400 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $18,167,971 | 20,507 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,726,419 | 21,788 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $17,827,731 | 22,916 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $13,894,481 | 23,836 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $9,448,116 | 17,590 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,529,538 | 22,452 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,947,769 | 23,143 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,154,207 | 22,289 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,513,562 | 20,144 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,438,783 | 10,606 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,668,686 | 12,811 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $3,466,561 | 12,550 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,763,342 | 16,288 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,140,081 | 18,038 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $2,647,799 | 14,173 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $4,064,823 | 24,075 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $3,725,811 | 25,171 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,316,395 | 8,018 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||